Early findings suggest clinical and lab-based

Early findings of two studies from the University of Michigan Rogel Cancer Center shed light on new ways to anticipate recurrence in HPV-positive head and neck cancer sooner.

Related Keywords

United States ,American ,Jennifer Shah ,Francisp Worden ,Mary Olesnavich ,Paul Swiecicki ,Andrewj Rosko ,Chandan Bhambhani ,Sarahm Dermody ,Keitha Casper ,Andrewg Shuman ,Chazl Stucken ,Erin Sandford ,Apurvad Bhangale ,Heatherm Walline ,Jonathanb Mchugh ,Luliaa Kana ,Kellym Malloy ,Catherinet Haring ,Michelle Mierzwa ,Collin Brummel ,Matthewe Spector ,Muneesh Tewari ,Stevenb Chinn ,Neck Oncology Program ,Rogel Cancer Center ,University Of Michigan Rogel Cancer Center ,Method Of Research ,American Cancer Society Grant ,Michigan Rogel Cancer Center ,Oral Oncology ,Oncology Clinical Trials Support Unit ,Chad Brenner ,Neck Oncology ,Markep Prince ,Kirstenl Tuck ,